Clinical Research

parexel-opens-its-6th-office-in-china-located-in-shenyang

Parexel opens its 6th office in China

  • China
  • |
  • News

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the country and throughout the Asia Pacific region. The... Read more

merck-serono-quintiles-sign-clinical-research-deal

Merck Serono, Quintiles sign clinical research deal...


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collaboration... Read more

kansas-bioscience-authority-kba-pays-received-usd400-000-to-pra-create-80-new-jobs

US state pays PRA $0.4 mn for creating jobs


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority... Read more

asia-has-potential-for-clinical-trials-but-no-country-has-yet-emerged-as-a-clear-winner

There are no winners in the clinical trials race in Asia

  • Singapore
  • |
  • Opinion
  • |
  • By Dr Wai Chiong Loke
  • |
  • 0 Comment

Over the past few decades, research on clinical trials has enjoyed a rapid boom around the world. According to CenterWatch, an established... Read more

several-conflicting-trends-have-emerged-in-pharmacovigilance-in-asia-photo-www

Pharmacovigilance: A strategic opportunity

  • China
  • |
  • Opinion
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As product safety continues... Read more

Biotech-310x175_copy

Quintiles appoints new VP for Asia lab

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Quintiles appointed Ms Jenny Zhang as VP and general manager of Asian laboratories. She will be responsible for Quintiles' laboratory... Read more

australia-has-a-favourable-environment-and-regulatory-system-for-clinical-research

Australia is the new hotspot for clinical research

  • Australia
  • |
  • Opinion
  • |
  • By Mr Mario Pennisi
  • |
  • 0 Comment

As everyone already knows, the international pharmaceutical industry is currently undergoing a number of significant changes brought on... Read more

dr-malcolm-burgess-executive-vice-president-asia-pacific-icon

Fight between local and global CROs intensifies

  • China
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Mr Malcolm Burgess relocated to Hong Kong in 2011 to take up the role of executive vice president of ICON with special responsibility for... Read more

spinifex-postherpetic-neuralgia-trial-is-a-success

Spinifex phase II postherpetic neuralgia trial is a success

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, revealed positive headline results from the phase II... Read more

pra-office-beijing

PRA expands in China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a clinical research organization, has opened a second office in China to accommodate its continued expansion in the country... Read more

sfda-certificate-glp-wuxi

WuXi facility gets SFDA certificate

  • China
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The toxicology facility of WuXi PharmaTech at Suzhou, China, has received a certificate of Good Laboratory Practice (GLP) from... Read more

cdsco-clinical-trial-guidelines

Indian authority invites opinion on guidelines for clinical trials

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: The Central Drug Standard Control Organization (CDSCO ), the governing authority in India for conducting clinical trials, has released... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X